Francisella FlmX broadly affects lipopolysaccharide modification and virulence
Chui-Yoke Chin,
Jinshi Zhao,
Anna C. Llewellyn,
Igor Golovliov,
Anders Sjöstedt,
Pei Zhou,
David S. Weiss
Affiliations
Chui-Yoke Chin
Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA
Jinshi Zhao
Department of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA
Anna C. Llewellyn
Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA
Igor Golovliov
Clinical Bacteriology, and Laboratory for Molecular Infection Medicine Sweden, Department of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden
Anders Sjöstedt
Clinical Bacteriology, and Laboratory for Molecular Infection Medicine Sweden, Department of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden
Pei Zhou
Department of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA
David S. Weiss
Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA; Research Service, Atlanta VA Medical Center, Decatur, GA 30033, USA; Corresponding author
Summary: The outer membrane protects Gram-negative bacteria from the host environment. Lipopolysaccharide (LPS), a major outer membrane constituent, has distinct components (lipid A, core, O-antigen) generated by specialized pathways. In this study, we describe the surprising convergence of these pathways through FlmX, an uncharacterized protein in the intracellular pathogen Francisella. FlmX is in the flippase family, which includes proteins that traffic lipid-linked envelope components across membranes. flmX deficiency causes defects in lipid A modification, core remodeling, and O-antigen addition. We find that an F. tularensis mutant lacking flmX is >1,000,000-fold attenuated. Furthermore, FlmX is required to resist the innate antimicrobial LL-37 and the antibiotic polymyxin. Given FlmX’s central role in LPS modification and its conservation in intracellular pathogens Brucella, Coxiella, and Legionella, FlmX may represent a novel drug target whose inhibition could cripple bacterial virulence and sensitize bacteria to innate antimicrobials and antibiotics.